StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
002899.SZ$25.99-4.45%
Fair $25.99+0.0%

002899.SZ

Impulse (Qingdao) Health Tech Co.,Ltd.

Consumer Cyclical / LeisureShenzhen

$25.99

-1.21 (-4.45%)

Fairly Valued+0.0%Fair Value $25.99Fund rank 25/100 · Data gapFallback financials|
SA 49/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $32.6M · quality 40.3/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 3.6%, below the 5% threshold
Thesis & Journal · 002899.SZLocal privado en este navegador · Impulse (Qingdao) Health Tech Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.8B

P/E

60.4x

↑

EV/EBITDA

23.7x

↑

ROE

3.6%

↓

Gross Margin

26.8%

↓

Debt/Equity

0.36

↓
52-Week Range$26
$20$36

TradingView lightweight chart

002899.SZ price, volumen y niveles de valoración

Último $25.99Periodo +12.5%
Fair value: $25.99

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.6%

FCF CAGR

—

FCF margin

5.0%

FCF / Net income

0.93x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.18B · net income $63.0M · FCF $58.7M

2022-FY → 2025-FY

Gross margin

26.8%+0.6% pts

Operating margin

7.1%-0.5% pts

Net margin

5.4%-2.6% pts

FCF margin

5.0%+47.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.18B$1.18B$1.21B$895.3M$824.7M
Net Income$63.0M$63.0M$109.1M$88.2M$65.7M
EBITDA$174.8M$174.8M$202.0M$121.0M$67.7M
EPS0.430.430.790.730.55
Gross Margin26.8%26.8%31.7%31.9%26.2%
Operating Margin7.1%7.1%13.0%12.0%7.6%
Net Margin5.4%5.4%9.0%9.8%8.0%
Balance Sheet
Debt/Equity0.360.360.420.550.53
Current Ratio2.102.10———
Cash Flow
Free Cash Flow$58.7M$58.7M$32.6M$-47.7M$-350.6M
Returns
ROE3.6%3.6%6.4%7.1%5.7%
Valuation
P/E60.4460.4427.8423.0823.00
EV/EBITDA23.7323.7316.1719.2625.75
P/B2.172.171.781.641.30
Growth & Yield
Revenue Growth-3.1%-3.1%35.6%8.6%—
EPS Growth-45.6%-45.6%8.2%32.7%—
Dividend Yield0.3%0.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

75.0%

muy exigente

EPS terminal req.

$2.31

Spread vs growth

-120.6%

5Y implied EPS CAGR

45.4%

muy exigente

EPS terminal req.

$2.79

Spread vs growth

-90.9%

10Y implied EPS CAGR

26.4%

muy exigente

EPS terminal req.

$4.49

Spread vs growth

-72.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +27.4%

Total return

+27.4%

Start / end P/E

25.9x → 60.4x

EPS bridge

0.79 → 0.43

Residual

-60.8%

EPS growth-45.6%
Multiple rerating+133.5%
Dividend+0.3%
Residual / FX / buybacks / cross-term-60.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.